Sun Pharma slips 1%; withdraws lawsuit against US health regulator
The company has withdrawn its appeal in the lawsuit filed by Ranbaxy against the US health regulator challenging FDA’s decision to revoke approvals for generic versions of Nexium and Valcyte.